165 related articles for article (PubMed ID: 19349174)
1. Induction of apoptosis promoted by Bang52; a small molecule that downregulates Bcl-x(L).
Rossi M; Bang JK; Mazur S; Iera JA; Phillips DC; Zambetti GP; Appella DH
Bioorg Med Chem Lett; 2009 May; 19(9):2429-34. PubMed ID: 19349174
[TBL] [Abstract][Full Text] [Related]
2. p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.
Müer A; Overkamp T; Gillissen B; Richter A; Pretzsch T; Milojkovic A; Dörken B; Daniel PT; Hemmati P
J Biol Chem; 2012 May; 287(21):17343-17352. PubMed ID: 22354970
[TBL] [Abstract][Full Text] [Related]
3. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
Zheng CH; Yang H; Zhang M; Lu SH; Shi D; Wang J; Chen XH; Ren XH; Liu J; Lv JG; Zhu J; Zhou YJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):39-44. PubMed ID: 22172701
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.
Kutuk O; Arisan ED; Tezil T; Shoshan MC; Basaga H
Carcinogenesis; 2009 Sep; 30(9):1517-27. PubMed ID: 19578044
[TBL] [Abstract][Full Text] [Related]
6. Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways.
Pirouzpanah MB; Sabzichi M; Pirouzpanah S; Chavoshi H; Samadi N
Asian Pac J Cancer Prev; 2015; 16(5):2087-92. PubMed ID: 25773855
[TBL] [Abstract][Full Text] [Related]
7. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
He CW; Liu F; Zhang YF; Liang T; Zhou KY
Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
[TBL] [Abstract][Full Text] [Related]
8. Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line.
Schoop RA; Kooistra K; Baatenburg De Jong RJ; Noteborn MH
Int J Cancer; 2004 Mar; 109(1):38-42. PubMed ID: 14735465
[TBL] [Abstract][Full Text] [Related]
9. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
Yang B; Reynolds CP
Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660
[TBL] [Abstract][Full Text] [Related]
10. Small molecules targeting p53 to improve antitumor therapy.
Beretta GL; Gatti L; Benedetti V; Perego P; Zunino F
Mini Rev Med Chem; 2008 Aug; 8(9):856-68. PubMed ID: 18691143
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.
Nita ME; Nagawa H; Tominaga O; Tsuno N; Fujii S; Sasaki S; Fu CG; Takenoue T; Tsuruo T; Muto T
Br J Cancer; 1998 Oct; 78(8):986-92. PubMed ID: 9792140
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
[TBL] [Abstract][Full Text] [Related]
13. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
[TBL] [Abstract][Full Text] [Related]
14. Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737.
Stauffer SR
Curr Top Med Chem; 2007; 7(10):961-5. PubMed ID: 17508927
[TBL] [Abstract][Full Text] [Related]
15. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
[TBL] [Abstract][Full Text] [Related]
16. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
17. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L
Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
19. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.
Simonin K; Brotin E; Dufort S; Dutoit S; Goux D; N'diaye M; Denoyelle C; Gauduchon P; Poulain L
Mol Cancer Ther; 2009 Nov; 8(11):3162-70. PubMed ID: 19887550
[TBL] [Abstract][Full Text] [Related]
20. Pro-apoptotic carboxamide analogues of natural fislatifolic acid targeting Mcl-1 and Bcl-2.
Gapil Tiamas S; Daressy F; Abou Samra A; Bignon J; Steinmetz V; Litaudon M; Fourneau C; Hoong Leong K; Ariffin A; Awang K; Desrat S; Roussi F
Bioorg Med Chem Lett; 2020 Apr; 30(7):127003. PubMed ID: 32035700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
